Bisphosphonates for treating osteoporosis (TA464)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 8 July 2019Published: 9 August 2017
Denosumab for the prevention of osteoporotic fractures in postmenopausal women (TA204)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 October 2010
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures (TA279)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 April 2013
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (TA161)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 7 February 2018Published: 27 October 2008
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (TA160)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 7 February 2018Published: 27 October 2008
Romosozumab for treating severe osteoporosis (TA791)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2022